Russell Investments Group
CERE

Russell Investments Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Russell Investments Group’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,128
Closed -$46.1K – 3846
2024
Q2 		$46.1K Buy
+1,128
New +$47K ﹤0.01% 2782
2023
Q3 		– Sell
-9
Closed -$286 – 3649
2023
Q2 		$286 Buy
+9
New +$276 ﹤0.01% 3399

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Russell Investments Group's CERE Position: Q3 2024 in Review

Russell Investments Group sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 1,128 shares — an estimated $46.1K sold.

Russell Investments Group first reported a position in CERE in Q2 2023 and held it in 2 quarters. The position peaked at $46.1K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Russell Investments Group reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Russell Investments Group sold 1,128 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $46.1K.
  • Russell Investments Group first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Russell Investments Group's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $46.1K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.